DE2331049A1 - 2,4-benzoxazepin-derivate und verfahren zu deren herstellung - Google Patents
2,4-benzoxazepin-derivate und verfahren zu deren herstellungInfo
- Publication number
- DE2331049A1 DE2331049A1 DE2331049A DE2331049A DE2331049A1 DE 2331049 A1 DE2331049 A1 DE 2331049A1 DE 2331049 A DE2331049 A DE 2331049A DE 2331049 A DE2331049 A DE 2331049A DE 2331049 A1 DE2331049 A1 DE 2331049A1
- Authority
- DE
- Germany
- Prior art keywords
- chloro
- phenyl
- hydrogen
- yield
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 18
- 238000002360 preparation method Methods 0.000 title claims description 4
- NOVUGKLPAQYFSW-UHFFFAOYSA-N 2,4-benzoxazepine Chemical class O1C=NC=C2C=CC=CC2=C1 NOVUGKLPAQYFSW-UHFFFAOYSA-N 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims description 18
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 13
- -1 alkoxy radical Chemical class 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims description 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 3
- GRSTVVGJSKHCCS-UHFFFAOYSA-N bis(1h-imidazol-2-yl)methanone Chemical compound N=1C=CNC=1C(=O)C1=NC=CN1 GRSTVVGJSKHCCS-UHFFFAOYSA-N 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Substances OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 30
- 238000002844 melting Methods 0.000 description 17
- 230000008018 melting Effects 0.000 description 17
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 235000019445 benzyl alcohol Nutrition 0.000 description 7
- 239000007858 starting material Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 125000006309 butyl amino group Chemical group 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- QILSFLSDHQAZET-UHFFFAOYSA-N diphenylmethanol Chemical class C=1C=CC=CC=1C(O)C1=CC=CC=C1 QILSFLSDHQAZET-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000006308 propyl amino group Chemical group 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- NAFYNIMFJVHWLO-UHFFFAOYSA-N [2-(aminomethyl)-5-chlorophenyl]-phenylmethanol Chemical compound NCC1=CC=C(Cl)C=C1C(O)C1=CC=CC=C1 NAFYNIMFJVHWLO-UHFFFAOYSA-N 0.000 description 2
- OOJAOGKXAKBVSY-UHFFFAOYSA-N [2-(methylaminomethyl)phenyl]-phenylmethanol Chemical compound CNCC1=CC=CC=C1C(O)C1=CC=CC=C1 OOJAOGKXAKBVSY-UHFFFAOYSA-N 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- ZCXLTWVZYXBHJS-UHFFFAOYSA-N 1,2-benzoxazepine Chemical group O1N=CC=CC2=CC=CC=C12 ZCXLTWVZYXBHJS-UHFFFAOYSA-N 0.000 description 1
- GHIZJXTXUGGZGO-UHFFFAOYSA-N 4-butyl-7-chloro-5-phenyl-1,5-dihydro-2,4-benzoxazepin-3-one Chemical compound ClC=1C=CC2=C(C(N(C(OC2)=O)CCCC)C2=CC=CC=C2)C1 GHIZJXTXUGGZGO-UHFFFAOYSA-N 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- DWYPVPVUZFBZNU-UHFFFAOYSA-N 7-chloro-5-phenyl-4-propyl-1,5-dihydro-2,4-benzoxazepin-3-one Chemical compound ClC=1C=CC2=C(C(N(C(OC2)=O)CCC)C2=CC=CC=C2)C1 DWYPVPVUZFBZNU-UHFFFAOYSA-N 0.000 description 1
- ACTWEYVIIAEZCE-UHFFFAOYSA-N 8-chloro-1-phenyl-4-propyl-1,5-dihydro-2,4-benzoxazepin-3-one Chemical compound ClC1=CC2=C(CN(C(OC2C2=CC=CC=C2)=O)CCC)C=C1 ACTWEYVIIAEZCE-UHFFFAOYSA-N 0.000 description 1
- FBEHFRAORPEGFH-UHFFFAOYSA-N Allyxycarb Chemical compound CNC(=O)OC1=CC(C)=C(N(CC=C)CC=C)C(C)=C1 FBEHFRAORPEGFH-UHFFFAOYSA-N 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- TXEXSDYBHKCIDV-UHFFFAOYSA-N [2-(butylaminomethyl)phenyl]-phenylmethanol Chemical compound C(CCC)NCC1=C(C(C2=CC=CC=C2)O)C=CC=C1 TXEXSDYBHKCIDV-UHFFFAOYSA-N 0.000 description 1
- JPMSHYCFOXPOKC-UHFFFAOYSA-N [2-(ethylaminomethyl)phenyl]-phenylmethanol Chemical compound C(C)NCC1=C(C(C2=CC=CC=C2)O)C=CC=C1 JPMSHYCFOXPOKC-UHFFFAOYSA-N 0.000 description 1
- GBRGSXMMXPCJHT-UHFFFAOYSA-N [2-[(benzylamino)methyl]phenyl]-phenylmethanol Chemical compound C(C1=CC=CC=C1)NCC1=C(C(C2=CC=CC=C2)O)C=CC=C1 GBRGSXMMXPCJHT-UHFFFAOYSA-N 0.000 description 1
- JIHDWBPVBCKZBY-UHFFFAOYSA-N [5-chloro-2-(ethylaminomethyl)phenyl]-phenylmethanol Chemical compound ClC=1C=CC(=C(C(C2=CC=CC=C2)O)C1)CNCC JIHDWBPVBCKZBY-UHFFFAOYSA-N 0.000 description 1
- IIDPYXREYOWZTJ-UHFFFAOYSA-N [5-chloro-2-(methylaminomethyl)phenyl]-phenylmethanol Chemical compound CNCC1=C(C=C(Cl)C=C1)C(O)C1=CC=CC=C1 IIDPYXREYOWZTJ-UHFFFAOYSA-N 0.000 description 1
- MJWGOHHXCUDMHZ-UHFFFAOYSA-N [5-chloro-2-(propylaminomethyl)phenyl]-phenylmethanol Chemical compound C(CC)NCC1=C(C(C2=CC=CC=C2)O)C=C(C=C1)Cl MJWGOHHXCUDMHZ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 125000005910 alkyl carbonate group Chemical group 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004973 motor coordination Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- AJYOOHCNOXWTKJ-UHFFFAOYSA-N p-Chlorobenzhydrol Chemical compound C=1C=C(Cl)C=CC=1C(O)C1=CC=CC=C1 AJYOOHCNOXWTKJ-UHFFFAOYSA-N 0.000 description 1
- WULICNNFJUHBIR-UHFFFAOYSA-N phenyl-[2-(propylaminomethyl)phenyl]methanol Chemical compound C(CC)NCC1=C(C(C2=CC=CC=C2)O)C=CC=C1 WULICNNFJUHBIR-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/06—Seven-membered rings having the hetero atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2611072 | 1972-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2331049A1 true DE2331049A1 (de) | 1974-01-10 |
Family
ID=11218650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2331049A Pending DE2331049A1 (de) | 1972-06-23 | 1973-06-19 | 2,4-benzoxazepin-derivate und verfahren zu deren herstellung |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US3817987A (en:Method) |
| JP (1) | JPS4949981A (en:Method) |
| AR (1) | AR197238A1 (en:Method) |
| AT (1) | AT329569B (en:Method) |
| AU (1) | AU5719073A (en:Method) |
| BE (1) | BE801309A (en:Method) |
| CA (1) | CA982127A (en:Method) |
| CH (1) | CH572476A5 (en:Method) |
| DD (1) | DD105231A5 (en:Method) |
| DE (1) | DE2331049A1 (en:Method) |
| ES (1) | ES416222A1 (en:Method) |
| FR (1) | FR2189069B1 (en:Method) |
| GB (1) | GB1384660A (en:Method) |
| HU (1) | HU165565B (en:Method) |
| IL (1) | IL42304A0 (en:Method) |
| LU (1) | LU67853A1 (en:Method) |
| NL (1) | NL7308613A (en:Method) |
| PL (1) | PL90070B1 (en:Method) |
| RO (1) | RO63447A (en:Method) |
| SE (1) | SE385299B (en:Method) |
| SU (1) | SU528874A3 (en:Method) |
| ZA (1) | ZA733262B (en:Method) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1090611A (en) * | 1963-05-22 | 1967-11-08 | Lepetit Spa | 4,1-benzoxazepine derivatives |
-
1973
- 1973-05-15 ZA ZA733262A patent/ZA733262B/xx unknown
- 1973-05-15 GB GB2307073A patent/GB1384660A/en not_active Expired
- 1973-05-18 IL IL42304A patent/IL42304A0/xx unknown
- 1973-05-23 US US00363225A patent/US3817987A/en not_active Expired - Lifetime
- 1973-06-15 CH CH873073A patent/CH572476A5/xx not_active IP Right Cessation
- 1973-06-19 DE DE2331049A patent/DE2331049A1/de active Pending
- 1973-06-20 RO RO7300075195A patent/RO63447A/ro unknown
- 1973-06-20 AT AT541873A patent/AT329569B/de not_active IP Right Cessation
- 1973-06-21 NL NL7308613A patent/NL7308613A/xx unknown
- 1973-06-21 LU LU67853A patent/LU67853A1/xx unknown
- 1973-06-21 SE SE7308807A patent/SE385299B/xx unknown
- 1973-06-21 AU AU57190/73A patent/AU5719073A/en not_active Expired
- 1973-06-22 BE BE132604A patent/BE801309A/xx unknown
- 1973-06-22 SU SU1931566A patent/SU528874A3/ru active
- 1973-06-22 CA CA174,789A patent/CA982127A/en not_active Expired
- 1973-06-22 AR AR248679A patent/AR197238A1/es active
- 1973-06-22 HU HULE710A patent/HU165565B/hu unknown
- 1973-06-22 JP JP48070679A patent/JPS4949981A/ja active Pending
- 1973-06-22 FR FR7322905A patent/FR2189069B1/fr not_active Expired
- 1973-06-22 DD DD171776A patent/DD105231A5/xx unknown
- 1973-06-23 PL PL1973163544A patent/PL90070B1/pl unknown
- 1973-06-23 ES ES416222A patent/ES416222A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| RO63447A (fr) | 1978-08-15 |
| GB1384660A (en) | 1975-02-19 |
| PL90070B1 (en:Method) | 1976-12-31 |
| DD105231A5 (en:Method) | 1974-04-12 |
| IL42304A0 (en) | 1973-07-30 |
| AR197238A1 (es) | 1974-03-22 |
| AT329569B (de) | 1976-05-25 |
| ES416222A1 (es) | 1976-03-01 |
| SE385299B (sv) | 1976-06-21 |
| LU67853A1 (en:Method) | 1973-08-30 |
| JPS4949981A (en:Method) | 1974-05-15 |
| ATA541873A (de) | 1975-08-15 |
| US3817987A (en) | 1974-06-18 |
| FR2189069A1 (en:Method) | 1974-01-25 |
| CA982127A (en) | 1976-01-20 |
| CH572476A5 (en:Method) | 1976-02-13 |
| SU528874A3 (ru) | 1976-09-15 |
| BE801309A (fr) | 1973-10-15 |
| HU165565B (en:Method) | 1974-09-28 |
| ZA733262B (en) | 1974-04-24 |
| FR2189069B1 (en:Method) | 1976-10-22 |
| AU5719073A (en) | 1975-01-09 |
| NL7308613A (en:Method) | 1973-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2901181C2 (de) | N-(1-Alkyl- bzw. Allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-alkylsulfonylbenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DD233126A5 (de) | Verfahren zur herstellung von pyridin-n-oxiden | |
| DE1695753B2 (de) | Verfahren zur Herstellung von 6,6disubstituierten 2,2-Dimethyl-4-oxopiperidinen | |
| DE1159462B (de) | Verfahren zur Herstellung von s-Triazinderivaten | |
| DE2166752A1 (de) | Pyridazinderivate | |
| CH412889A (de) | Verfahren zur Herstellung von 2-Methyl-3-oxypyridinen | |
| DE2462559C3 (de) | 4-Oximino-l -oxa-S-thiacyclopentane und deren 3-Oxide bzw. 33-Dioxide sowie S-Oximino-l-oxa^-thiacyclohexane und deren 4-Oxide bzw. 4,4-Dioxide | |
| DE2841644C2 (en:Method) | ||
| DE2420474B2 (de) | Verfahren zur herstellung von benzoinaethern | |
| DE2331049A1 (de) | 2,4-benzoxazepin-derivate und verfahren zu deren herstellung | |
| DE1292664B (de) | 1, 2, 3, 5, 6-Pentathiacycloheptan, Verfahren zu dessen Herstellung und Verwendung | |
| DE2628469C3 (de) | Verfahren zur Herstellung von γ -Aminoalkoholen | |
| EP0046193B1 (de) | 1-Hydroxypyrazol und Verfahren zu seiner Herstellung | |
| DE2458257C2 (de) | 1'-Desmethyl-1'-(β-hydroxyäthyl)-clindamycin-2-phosphat, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel | |
| DE3906855A1 (de) | Verfahren zur herstellung von cytosinen | |
| DE2164662A1 (de) | Indanderivate und Verfahren zu ihrer Herstellung | |
| EP0602549B1 (de) | 4-Hydroxy-2,3,5-trifluorbenzoesäure und Verfahren zu ihrer Herstellung | |
| AT272350B (de) | Verfahren zur Herstellung von 2,3-Dihydro-1H-1,4-benzodiazepinen und von Säureadditionssalzen dieser Verbindungen | |
| EP0175264B1 (de) | Verfahren zur Herstellung von 2-Amino-3-cyano-5-dialkoxymethyl-pyrazinen und Zwischenprodukte für dieses Verfahren | |
| DE19713506A1 (de) | Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere | |
| EP0552759A1 (de) | Verfahren zur Herstellung von 4,6-Dialkoxypyrimidinen | |
| DE2005108C3 (de) | Verfahren zur Herstellung von 5,5-disubstituierten 1,3-Dialkyloxymethyl- oder 13-Dibenzyloxvmethylverbindungen der Barbitursäure | |
| AT371445B (de) | Verfahren zur herstellung von neuen cis-4a-phenyl-isochinolinderivaten und ihren saeureadditionssalzen | |
| DE1929237A1 (de) | Verfahren zur Herstellung von N-Acyl-3,4-epoxy-pyrrolidin-Derivaten | |
| DE2015731C3 (de) | Azamorphinanverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen |